人民同泰(600829) - 投资者活动记录表(2023年11月8日)
HRPCHRPC(SH:600829)2023-11-09 10:13

Group 1: Company Overview - The company primarily operates in pharmaceutical wholesale, retail, logistics, and medical services [1] - Pharmaceutical wholesale business accounts for approximately 84% of total revenue, while retail business contributes about 15% [1] - The company has established a modern pharmaceutical logistics distribution center in Heilongjiang Province [1] Group 2: Financial Performance - In Q3 2023, the company achieved a revenue of 7.825 billion CNY, representing a year-on-year increase of 25.39% [1] - The net profit for the same period was 156 million CNY, reflecting a growth of 7.84% [1] - The company’s strategic development plan for 2023-2027 was established under the new board of directors [1] Group 3: Interactive Q&A - Investors inquired about the scale of the company's wholesale business and the status of DTP pharmacies [1] - The company engaged in thorough communication with investors during the meeting [3]

HRPC-人民同泰(600829) - 投资者活动记录表(2023年11月8日) - Reportify